Dowling Patricia M
Department of Veterinary Biomedical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4, Canada.
Vet Clin North Am Small Anim Pract. 2005 May;35(3):557-69. doi: 10.1016/j.cvsm.2004.12.012.
When faced with the geriatric dog or cat, the practitioner should consider the following: 1. Avoid using any drugs at all unless there are definite therapeutic indications. If the patient has some degree of renal insufficiency, try to select drugs that are hepatically metabolized and excreted in bile rather than eliminated by the kidneys (eg, doxycycline, tolfenamic acid). If hepatic insufficiency is present, select drugs that do not undergo metabolism before renal excretion (eg, penicillins, cephalosporins). 2. If therapeutic drug monitoring is available, tailor the drug dosage regimen to that specific patient (eg, phenobarbital, digoxin, amino-glycosides). 3. If therapeutic drug monitoring is unavailable, determine if there are clinically proven adjusted dosage regimens for specific drugs. The package insert on human pharmaceutics often gives guidelines for adjusting dosages in geriatric patients. 4. If the drug has not been sufficiently studied to have dosage adjustment recommendations, determine if there is sufficient information about its kinetics to estimate the proper drug dose in a geriatric patient. Some general guidelines for commonly used drugs in geriatric veterinary patients are provided in Table 1. In general, if the Vd changes in your patient, change the dose. If the elimination half-life changes, change the dosing interval. 5. Carefully monitor treated patients for signs of efficacy and toxicity.
面对老年犬猫时,从业者应考虑以下几点:1. 除非有明确的治疗指征,否则应完全避免使用任何药物。如果患者有一定程度的肾功能不全,尽量选择经肝脏代谢并通过胆汁排泄而非经肾脏消除的药物(如强力霉素、托芬那酸)。如果存在肝功能不全,选择在经肾脏排泄前不进行代谢的药物(如青霉素、头孢菌素)。2. 如果有治疗药物监测,根据特定患者调整药物剂量方案(如苯巴比妥、地高辛、氨基糖苷类)。3. 如果没有治疗药物监测,确定是否有针对特定药物的经临床验证的调整剂量方案。人用药品的包装说明书通常会给出老年患者调整剂量的指导原则。4. 如果对某种药物的研究不足以给出剂量调整建议,确定是否有足够的关于其动力学的信息来估计老年患者的合适药物剂量。表1提供了老年兽医患者常用药物的一些一般指导原则。一般来说,如果患者的分布容积发生变化,就改变剂量。如果消除半衰期发生变化,就改变给药间隔。5. 仔细监测接受治疗的患者的疗效和毒性迹象。